Overview
Watchlist
Equities
Crypto
Soon
Popular
Home
Equities
ASLN
Fundamentals

Aslan Pharmaceuticals Ltd

ASLN

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

0.00
0.000.00%
-

Assets

24.63M
▼-30.58M▼-55.39%
6 Months Change

Liabilities

37.91M
▼-10.92M▼-22.36%
6 Months Change

Free Cash Flow

-46.65M
▼-8.22M▼-21.38%
12 Months Change

Revenue/Cost Of Revenue

Net Profit/Loss

Assets/Liabilities

Cash Flows

Earnings Per Share

Outstanding Shares

Recent Quarterly and Annual Filings

2024-04-12
Form 20-F
ID: 0000950170-24-043860
2023-03-24
Form 20-F
ID: 0000950170-23-009599
2022-03-25
Form 20-F
ID: 0001564590-22-011742
2021-04-23
Form 20-F
ID: 0001564590-21-020241
2020-04-16
Form 20-F
ID: 0001564590-20-016974
2019-04-29
Form 20-F
ID: 0001564590-19-013503